Rice Hall James & Associates, LLC Acadia Pharmaceuticals Inc Transaction History

Rice Hall James & Associates, LLC

$1.69 Billion
Q3 2024

A detailed history of Rice Hall James & Associates, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Rice Hall James & Associates, LLC holds 717,146 shares of ACAD stock, worth $11.7 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

717,146

Previous 742,935 3.47%

Holding current value

$11.7 Million

Previous $12.1 Million 8.58%

% of portfolio

0.65%

Previous 0.79%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$15.14 - $19.14 $390,445 - $493,601	-25,789 Reduced 3.47%	717,146 $11 Million
Q2 2024 Aug 07, 2024	BUY	$14.62 - $18.42 $1.15 Million - $1.44 Million	78,379 Added 11.79%	742,935 $12.1 Million
Q1 2024 Apr 23, 2024	SELL	$17.79 - $30.86 $503,385 - $873,214	-28,296 Reduced 4.08%	664,556 $12.3 Million
Q4 2023 Feb 08, 2024	SELL	$20.78 - $31.77 $66,766 - $102,077	-3,213 Reduced 0.46%	692,852 $21.7 Million
Q3 2023 Nov 02, 2023	SELL	$20.84 - $33.47 $3.97 Million - $6.37 Million	-190,388 Reduced 21.48%	696,065 $14.5 Million
Q2 2023 Jul 24, 2023	SELL	$17.8 - $25.65 $11,979 - $17,262	-673 Reduced 0.08%	886,453 $21.2 Million
Q1 2023 May 11, 2023	SELL	$16.32 - $20.92 $1.15 Million - $1.48 Million	-70,562 Reduced 7.37%	887,126 $16.7 Million
Q4 2022 Jan 27, 2023	BUY	$14.2 - $18.63 $6.16 Million - $8.08 Million	433,818 Added 82.81%	957,688 $0
Q3 2022 Nov 01, 2022	SELL	$14.11 - $18.27 $277,374 - $359,151	-19,658 Reduced 3.62%	523,870 $8.57 Million
Q2 2022 Aug 08, 2022	BUY	$13.01 - $27.22 $1.04 Million - $2.18 Million	80,224 Added 17.32%	543,528 $7.66 Million
Q1 2022 May 05, 2022	BUY	$20.94 - $27.5 $47,177 - $61,957	2,253 Added 0.49%	463,304 $11.2 Million
Q4 2021 Feb 14, 2022	SELL	$16.79 - $27.09 $599,503 - $967,275	-35,706 Reduced 7.19%	461,051 $10.8 Million
Q3 2021 Nov 09, 2021	SELL	$15.78 - $24.77 $254,452 - $399,416	-16,125 Reduced 3.14%	496,757 $8.25 Million
Q2 2021 Jul 29, 2021	SELL	$19.4 - $27.42 $1.18 Million - $1.67 Million	-61,054 Reduced 10.64%	512,882 $12.5 Million
Q1 2021 May 14, 2021	BUY	$25.02 - $54.99 $7.5 Million - $16.5 Million	299,777 Added 109.34%	573,936 $14.8 Million
Q4 2020 Feb 16, 2021	SELL	$41.04 - $56.79 $33,652 - $46,567	-820 Reduced 0.3%	274,159 $14.7 Million
Q3 2020 Nov 16, 2020	BUY	$36.42 - $57.0 $3.02 Million - $4.73 Million	83,021 Added 43.25%	274,979 $11.3 Million
Q2 2020 Aug 14, 2020	SELL	$39.26 - $52.73 $162,418 - $218,144	-4,137 Reduced 2.11%	191,958 $9.3 Million
Q1 2020 May 15, 2020	BUY	$31.65 - $46.87 $6.21 Million - $9.19 Million	196,095 New	196,095 $8.29 Million

Others Institutions Holding ACAD

# of Institutions

280

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.63B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Hall James & Associates, LLC with notifications on news.

Account

Rice Hall James & Associates, LLC Acadia Pharmaceuticals Inc Transaction History